Pulmonary Mucomycosis Treated Successfully with Medical Therapy
Published: 2021-08-05
Page: 129-133
Issue: 2021 - Volume 4 [Issue 1]
A. Hedhli
University of Tunis El Manner, Faculty of Medicine of Tunis, Rabata Hospital, Pneumology Department, RL 18SP02, Tunis, Tunisia.
N. Mahmoud *
University of Tunis El Manner, Faculty of Medicine of Tunis, Rabata Hospital, Pneumology Department, RL 18SP02, Tunis, Tunisia.
S. Toujani
University of Tunis El Manner, Faculty of Medicine of Tunis, Rabata Hospital, Pneumology Department, RL 18SP02, Tunis, Tunisia.
Y. Ouahchi
University of Tunis El Manner, Faculty of Medicine of Tunis, Rabata Hospital, Pneumology Department, RL 18SP02, Tunis, Tunisia.
S. Cheikhrouhou
University of Tunis El Manner, Faculty of Medicine of Tunis, Rabata Hospital, Pneumology Department, RL 18SP02, Tunis, Tunisia.
J. Cherif
University of Tunis El Manner, Faculty of Medicine of Tunis, Rabata Hospital, Pneumology Department, RL 18SP02, Tunis, Tunisia.
J. Daghfous
University of Tunis El Manner, Faculty of Medicine of Tunis, Rabata Hospital, Pneumology Department, RL 18SP02, Tunis, Tunisia.
M. Mjid
University of Tunis El Manner, Faculty of Medicine of Tunis, Rabata Hospital, Pneumology Department, RL 18SP02, Tunis, Tunisia.
S. Merai
University of Tunis El Manner, Faculty of Medicine of Tunis, Rabata Hospital, Pneumology Department, RL 18SP02, Tunis, Tunisia.
*Author to whom correspondence should be addressed.
Abstract
Mucormycosis is a rare life-threatening fungal infection. It occurs usually in immunocompromized patients. We present a case of pulmonary mucormycosis in patient with poorly controlled diabetes. The diagnosis was suspected on radiological finding showing a right upper lobe cavitating consolidation and confirmated by isolating typical aspect of the pathogene within histological exam. Patient was treated by liposomal amphotericin B and had significant improvement.
Keywords: Pulmonary mucomycosis, medical therapy, fungal infection